Synthesis, Inhaltsverzeichnis Synthesis 2020; 52(22): 3485-3491DOI: 10.1055/s-0040-1706762 paper Synthesis of Chiral N-Nitro-oxazolidin-2-ones and O-(β-Nitraminoalkyl) Carbamates in Liquefied 1,1,1,2-Tetrafluoroethane Medium Svetlana S. Arabadzhi , Mikhail N. Zharkov , Ilya V. Kuchurov , Sergei G. Zlotin∗Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Abstract A convenient synthesis of chiral N-nitro-oxazolidin-2-ones by nitration of α-amino acid derived 1,3-oxazolidin-2-ones containing one or two stereogenic centers with dinitrogen pentoxide in liquefied 1,1,1,2-tetrafluoroethane medium has been developed. The obtained N-nitroheterocycles were converted into enantiomerically pure O-(β-nitraminoalkyl) carbamates by treatment with ammonia or amines in the same solvent. The synthesized N-nitro compounds are slightly toxic in vitro to Human Embryonic Kidney 293 (HEK293) cells. Key words Key wordsnitration - dinitrogen pentoxide - N-nitro-oxazolidin-2-ones - primary nitramines - 1,1,1,2-tetrafluoroethane Volltext Referenzen References 1 Klapötke TM. Chemistry of High-Energy Materials, 5th ed. Walter de Gruyter; Berlin: 2019: 385 2 Meyer R, Köhler J, Homburg A. Explosives, 6th ed. Wiley-VCH; Weinheim: 2007: 430 3 Nitric Oxide: Biology and Pathobiology, 3rd ed. Ignarro LJ, Freeman B. Academic Press; London: 2017: 434 4 Nitric Oxide Donors: For Pharmaceutical and Biological Applications . Wang PG, Cai TB, Taniguchi N. Wiley-VCH; Weinheim: 2005: 407 5 Bansinath M, Arbabha B, Turndorf H, Garg UC. Neurochem. Res. 1993; 18: 1063 6 Engin AB, Engin ED, Karakus R, Aral A, Gulbahar O, Engin A. Food Chem. Toxicol. 2017; 109: 465 7 Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor. Yamamoto I, Casida JE. Springer; Tokyo: 1999: 300 8 Yang D, Wan C, Xiao Y, Che C, Rui C, Qin Z. RSC Adv. 2018; 8: 1838 9 Wagner ED, Osiol J, Mitch WA, Plewa MJ. Environ. Sci. Technol. 2014; 48: 8203 10 Falb E, Nudelman A, Hassner A. Synth. Commun. 1993; 23: 2839 11 Brnardic EJ, Fraley ME, Garbaccio RM, Layton ME, Sanders JM, Culberson C, Jacobson MA, Magliaro BC, Hutson PH, O’Brien JA, Huszar SL, Uslaner JM, Fillgrove KL, Tang C, Kuo Y, Sur SM, Hartman GD. Bioorg. Med. Chem. Lett. 2010; 20: 3129 12 Rami M, Macherla R. US Patent 7879892, 2008 13 Madariaga MG, Swindells S. Antimicrob. Agents Chemother. 2007; 51: 1130 14 Kaushik А, Heuer AM, Bell DT, Culhane JC, Ebner DC, Parrish N, Ippoliti JT, Lamichhane G. Bioorg. Med. Chem. Lett. 2016; 26: 3572 15 Moellering RC. Ann. Intern. Med. 2003; 139: 864 16 Vale N. In Biomedical Chemistry: Current Trends and Developments. Walter de Gruyter; Berlin: 2015: 178 17 Froestl W. In Advances in Pharmacology, Vol. 58. Academic Press; London: 2010: 19 18 Zharkov MN, Kuchurov IV, Fomenkov IV, Tartakovsky VA, Fedyanin IV, Zlotin SG. Synthesis 2017; 49: 1103 19 Thermophysical Properties of Fluid Systems; (accessed August 5, 2020) ; http://webbook.nist.gov/chemistry/fluid 20 Refrigerants – Environmental Properties. The Engineering ToolBox; (accessed August 5, 2020); https://www.engineeringtoolbox.com/Refrigerants-Environment-Properties-d_1220.html 21 Gong C, Yang T, Yang X, Liu Y, Ang W, Tang J, Pi W, Xiong L, Chang Y, Ye W, Wang Z, Luo Y, Zhao X, Wei Y. Nanoscale 2013; 5: 275 22 Bruker. APEX-III. Bruker AXS Inc., Madison, Wisconsin, USA, 2018 23 Krause L, Herbst-Irmer R, Sheldrick GM, Stalke D. J. Appl. Crystallogr. 2015; 48: 3 24 Sheldrick GM. Acta Crystallogr., Sect. A: Found. Crystallogr. 2015; 71: 3 25 Sheldrick GM. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2015; 71: 3 26 Gruenhut NS, Goldfrank M, Cushing ML, Caesar GV, Caesar PD, Shoemaker C. In Inorganic Syntheses, Vol. III. Audrieth LF. McGraw-Hill; New York: 1950: 78 27 Mosmann TJ. Immunol. Methods 1983; 65: 55 Zusatzmaterial Zusatzmaterial Supporting Information